@venturebeat.com 6 years ago
KFx Medical, LLC Announces Another and Fourth License of its Knotless Double Row Patents
@venturebeat.com 6 years ago
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
@venturebeat.com 6 years ago
Medigate Announces $5.35M Seed Round to Protect Connected Medical Devices from Pandemic Cyberattacks Threatening Patient Safety and Privacy
@venturebeat.com 6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com 6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com 6 years ago
Protembis Announces Successful First-in-Human Use of Its ProtEmbo® Cerebral Protection System in European Trial
@venturebeat.com 6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com 6 years ago
Kony Announces New EASE Application to Enhance Patient Experience and Satisfaction
@venturebeat.com 6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com 7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@venturebeat.com 7 years ago
Svelte Medical Systems Announces Start of DIRECT III Post-Market Registry Study
@venturebeat.com 7 years ago
Svelte Medical Systems Announces CE Mark Certification of DIRECT RX™
@venturebeat.com 8 years ago
Portea Medical Announces US$37.5 Million Series B Funding Led by Accel